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We have recently reported a basic domain-mediated neurotosic activity of HIV-I Tat [1991. J. Virol. 65. 961-9651. Here we have tested the 
neurotoxicity in vivo of several Rev-related synthetic peptides and found that only those mimicking the basic regions of Rev from HIV-l. HIV-2 
and SIV wcrc lethal to mice. III contrast. the homologous domain of HTLV-1 Rex was found to be inactive for lethal activity. Analysisof the tropism 
of these peptides for phospholipids has demonstrated a direct interaction of the basic domain-containing peptides. except Rex. tvith acidic but 
not neutral - phospholipids. As determined by circular dichroism. a possible correlation between the conformation of the basic regions and the 
tosicity is discussed. 
Rctrovirus: T,ntrs-activator: Basic domain: Synthetic pepride: Ncurotosicity: Circular dichroism 
1. INTRODUCTION 
The human immunodeficiency virus (HIV). the cau- 
sative agent of acquired immune deficiency syndrome 
(AIDS) [I]. is characterized by a genome containing at 
least 10 separate open reading frames. Two of these. 
referred to as rev (formerly NIBS or trs) [2] and (of genes 
[3]. encode rrcrns-acting nuclear regulatory protein% 
whose functional expression is essential for viral replica- 
tion in vitro [4.5]. The HIV-l Rev and Tat ft.cril,r-activa- 
tors are 116 and 86 residue proteins. respectively. and 
are translated from overlapping reading frames enco- 
ded in two exons in the cttv region of the HIV genome. 
While the Tat protein dramatically increases the steady 
state levels of viral mRNAs and seems to function both 
transcriptionally and posttranscriptionally [6], the 
tl’(ot.s-activator Rev acts at the post-transcriptional evel 
and inducts the cytoplasmic expression of the unspliced 
gcig-@ mRNA and the singly spliced CJI)I’ mRNA that 
encode the structural proteins [2.4]. At the same time. 
RCV ~ISO modulates the level and quality 0fHIV rcgulit- 
tory gent expression [7]. The Rev-mediated cffcct dc- 
pcnds on a cs/‘.v-acting element located in the C~IIP region 
of HIV- I. named Rev-rcsponsivc clcmcnt (RRE) [8.9]. 
Uncxpcctcdly. it has been rcportcd thal HIV- I Rev can 
be functionally substituted by the nuclear human T-ceii 
leukemia virus type 1 (HTLV- 1) Rex protein (189 
amino-acid residues). although these phosphoproteins 
are distantly related and lack amino-acid similarity 
[ !3.1 I]. Furthermore. computer-generated predictions 
of secondary structure reveal no significant similarities 
between both /t.crtzs-activators. 
In a recent study. we have reported a basic domain- 
mediated neurotoxic activity of Tat from HIV- I [I 21. 
Interestingly. functional Rev proteins from HIV-l and 
related primate lentiviruses HIV-2 and SIV [I 31. as well 
as Rex from HTLV-I. contain an unusual highly basic 
region. As for Tat. mutational analyses suggest hat the 
arginine-rich region is essential for Rev Il*~rtt.+acting 
function and is important for nuclear translocation 
[7,14]. Here we have invcstigatcd with synthetic pcptidcs 
whether the basic domains of thcsc proteins were able 
to exhibit comparable ncurotoxicity. In addition. the 
basic domain-mimickiti~ pcptidcs huvc been tcstcd for 
a potential interaction with phospholipids using the mo- 
nomolecular film tcchniquc [ 151. ilnd their sccondar> 
structures in polar atId nonpolar sol\*cnts lvcrc asscsscd 
by CiKUliIr dichroism illliIl~SiS. 
Volume 289. number I FEES LETTERS September 1991 
[16.17]. Stepwise elongation of the peptide chains was carried out 
semi-automatically (synthesizer NPS 4000, Neosystem) on 4-(oxy- 
methyl)-phenylacetamidomethyl polystyrene resin (0.5 mmol) using 
r-butyloxycarbonyl (Boc)/benzyl chemistry. Side-chain protecting 
groups used for trifunctional Boc-amino acids were of the HF labile 
type. except for tryptophan (formyl). The coupling method was a 
formation of Boc-amino acid hydroxybenzotriazole active esters (2 
mmol) in N-methylpyrrolidone. After full assembly was compicted. 
deformylation of tryptophan-containing peptides was achieved on the 
resin by treatment in darkness with I M piperidine in dimcthylforma- 
mide (2 h. 0°C). Final dcprotection was achieved by anhydrous hydro- 
gen fluoride treatment. WFlp-cresollcthanedithiol (85:10:5. vol/vol). 
for 1 h at -5°C. The synthetic products were highly purified (>98%) 
by Clll reverse-phase medium pressure liquid chromatography and 
were characterized by C,, analytical HPLC and amino acid analysis 
after hydrolysis under vacuum (6 N HCI. I h. 150°C). 
2.2. .Speci$c ttc~tcrorctsicir~~ q/‘sjwt/icric pqzidcs it2 ttriw 
Determination of the 50% lethal dose (LD,,,) wasdonc by intracere- 
brovcntricular injection (5 ~1) of peptidc solutions in water containing 
0.1% (wt/vol) bovine serum albumin and 0.9% Wvol) sodium chlo- 
ride (eight 20-g C,;/BL, mice per dose). 
2.3. Motiorttitl~c~tlt~Jiltit leclttriq:re 
Surface pressure (n) was measured with a platinium plate tcnsiomc- 
ter according to the ‘Wilhelmy method [I 51. A cylindrical tcflon trough 
Table I 
Specific neurotoxicity of the Rev and Rex-related peptides in mice. 
The synthetic peptidcs wcrc tcstcd in vivo for their neurotosicity by 
determining the 50% lethal dose (LD,,,) inmice. Thcpeptidcs including 
the basic domain arc underlined. The LDS,, is cxpresscd in both micro- 
grams and nanomolcs (in parcnthescs) ofinoculated pcptidcs. Pcptidcs 
were considered inactive when nci\hcr neurotosicsymptoms nor lethal 
cffccts wcrc obscrvcd after injection of 200 fig. About thirty various 
length (,W,= 1500-8000) control pcptidcs. cithcr dcrivcd from HIV 
proteins or unrelated to HIV. wcrc found to be inactive (data not 
shown). Thcsc control peptidcs include highly basic compounds: frag- 
mcnt l-34 of human spleen H,b histonc. full-lcnglh histonc from call 
thymus or its fragments l-25 or II--38 from H:b and I.29 from H,. 
pcptide 1419..I444 from ,\I. ,gcttiru/itrttr adhcsin. and poly-L-lysinc (.II, 
= 3800). Protcolytic digestions of active pcplidcs wcrc controlled by 
Edman scqucncing. 
Pcptido LD:,, Wg) 
HIV-I I~ru. Rev l--l6 Inacrivc 
. . 
Rev Y. 26 
.a 
.I 
Rev IX 30 
.I 
.a 
Rev 31 -44 
.I 
II Rev 34 -5 I 57 (22.3) 
. . 
Rev 34 51 after cryptic digestion It1ac1iw 
.1 
lb3 37 50 12 (34,9) 
. . 
Rev 37 50 ilftcr lrytic cligcstion Ill;Ictiw 
. . 
Rev 52 04 
. . 
. . 
lb 7s XK 
.I 
I. 
I<cv x7 IO0 
.I 
I. 
I<ov ‘I6 I10 . . . . 
I<cv IO1 I I6 .I 
HIV-2 Rod. IW 34 4Y 35 (IS.11 
. . 
Rev 34 4Y nftsr trgtic digcslion Inxliw 
SIV IllIl~IJ!. Ihx 3.l 49 3.1 (l4.l) 
.I 
IicV 34 49 ill’tCr trgtic dipcslinn In;xliw 
SIV &IIl, Ib2v23 4s Jd (lb.O] 
. . 
I&v 23 45 :rftcr tryptic dipcatiw~ IllilCliVC 
I, I-l’f’1.V. Kcr I 17 IlDl Iclll;ll 
(tosir syi~ptu~ilx) 
.._ ._-_MY -.... _._.-L.- 1 
(6.3-cm diameter x 1.4 cm) was used in a temperature-controlled 
(25°C) chamber for constant surface experiments and enabled surface 
pressure variations to be determined (An). The phospholipid was first 
dissolved in chloroform at a concentration of Z mg/ml and was then 
gently deposited at the air-water interface with a microsyringe in order 
to obtain a lipid monolayer. For the aqueous phase, the buffer used 
was 100 mM NaCI. 21 mM CaC&. I mM EDTA. IO mM TrisHCI. 
pH 8. 
Low ultraviolet circular spcctroscopies were recorded on a Jobin- 
Yvon spectrophotomcter. (Longiumcau. France). The instrument was 
calibrated with (A_)-IO-camphorsulfonic acid. The spectra were per- 
formed at a temperature of 25°C by using a 0.5-mm pathlength cell. 
with a 2-s time constant and a scan rate of 0.5 rim/s.. The peptide 
concentration in the solutions, based on the absorption spectra, was 
of 500 .&/ml. The spectra were cumulated 5-fold in water or water- 
TFE and 3-fold in TFE. and automatically averaged. 
3. RESULTS 
We have tested by intracerebroventricular injections 
in mice a set of 11 synthetic peptides covering almost the 
full sequence of HIV-1 Rev. We found that only the 
basic domain-containing peptides Rev 34-51 and Rev 
37-50 were able to exhibit a lethal neurotoxicity with 
LDSo of 57 and 72 pg, respectively (Table I). The pep- 
tides including the basic sequences of Rev from HIV-2 
Rod, SIV mm142 and SIV Agm (Fig. 1) showed similar 
activity (LDSo of 35. 33 and 46 pug). In contrast, the 
homologous region of HTLV-I Rex was found to be 
non-lethal in mice at the tested dose of 200 ,ug, in spite 
of significant behavioral neurotoxic symptoms that 
could be detected from a lO+g dose and which totally 
disappeared within 1 11 post-inoculation. As shown in 
Table 1. the tryptic digestion of active Rev peptides 
resulted in complete loss of neurotoxicity. The specifi- 
city of this activity was also demonstrated by the unabi- 
lity of highly basic control peptides, such as poly-L- 
lysine, to induce neurotoxic symptoms and lethality in 
mice (data not shown). 
The possible interaction of the basic domain-contai- 
ning Rev and Rex peptides with specific phospholipids 
was studied by using the monomolecular film technique. 
HIV-I Bru. Rev 34 51: Tl~QARRSRRl~R~~‘RERQIZQ 
HIV-’ Rod Kcv 14 JY, _ , . SQRRNRl~Rl~~~‘KQl~\VRQ 
SIV 1n1nlJ2. Rev 34 4’): SQllI~QKRI~R~~l~QR~~QQ 
SIV /yiy~ Kc\, 23 45: ~I’l’S(;E:C’l’r\RQRI~- 
I?ARWRWRQQQ 
147’1,V I, Rcs I 17: ~It’K’l’l~RI~I’I~HS(l~Kl~l’l’ 
I;ig, I. Priiiiiiry slructurcx in Ilic one-lcltcr code. 0r the hilhic domiiin- 
ctmliiininp Rev ;Iiirl Rcs pcplidcs. 
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Table II 
Specificity of interactions between the basic domain-containing Rev 
and Res peptides and phospholipids using the monomolecular film 
technique. The peptides were tested on either neutral (dilaurylphos- 
phatidylcholine. DLPC) or negatively charged (dilaurylphosphatidyl- 
serine. DLPS) phospholipid monolayers. The surface pressure varia- 
tions (An) were measured in the presence of peptides (3pM) in contact 
with DLPC or DLPS monolayers at initial film pressures II of 10.90 
and IO.60 dynes/cm, respectively. The surface activity of peptides at 
the air-water interface is also reported. 
Peptides AR [air water] dtr [DLPC] AR [DLPS] 
(dynes/cm) 
HIV-I Bru, Rev 34-51 0.06 0.00 3.63 
HIV-2 Rod, Rev 34-49 0.37 0.00 6.13 
SIV mml42. Rev 3449 0.38 0.00 5.38 
SIV .4gm. Rev 23345 0.25 0.00 2.50 
HTLV-‘I. Rex l-17 0.00 0.00 0.00 
Results expressed in Table II show that the surface 
activity of Rev peptides became much greater in the 
presence of DLPS monolayer (An [DLPS] from 2.50 to 
6.13 dynes/cm) than that observed at the air-water in- 
terface (& [air-water] from 0.06 to 0.38). This indicates 
the capacity of toxic Rev peptides to penetrate nega- 
tively charged DLPS. but not neutral DLPC (drr 
[DLPCJ = 0) monolayers. The Rex peptide was unable 
to penetrate both types of phospholipid monolayers (An 
[DLPS] or [DLPC] = 0). 
Finally, secondary structures of the peptides solubili- 
zed in water, water-TFE or TFE solvents. were ap- 
proached by circular dichroism (CD) analysis (Fig. 2). 
The CD data show that active Rev peptides possess 
comparable organized structures in each solvent, which 
are mainly /3-turns/~-sheets (water) and cr-helices/@- 
30 
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sheets (TFE), while the Rex peptide was either partially 
structured in B-turns (water) or /&turns@-sheets (TFE). 
4. DISCUSSION 
We have reported a neurotoxic activity of HIV-l Tat 
[12], which was shown to be associated with the pres- 
ence of the conserved basic region from 49 to 57 (i.e. 
sequence RKKRRQRRR). The fruaws-activators Rev 
from HIV-l, HIV-2 and SIV. as well as Rex from 
HTLV-1. also possess highly basic domains which are 
presumed to contain nuclear-nucleolar targeting signals 
and/or RNA binding sites [ll]. Although the basic 
sequences of Rev proteins are not closely related to 
that of HIV-l Tat, except consensus motif 
RR[Q,N][R.K]RR, we have investigated with synthetic 
peptides whether these target regions were able to ex- 
hibit similar toxic activity. Fipst, the neurotoxicity of 
eleven synthetic peptides covering almost the full se- 
quence of HIV-l Rev was tested and second, that of the 
basic regions of HIV-2 and SIV Rev, and HTLV-I Rex. 
The activity of peptides was studied in vivo by intracere- 
broventricular injection in mice. Only the basic domain- 
containing Rev peptides were lethal to mice with clinical 
effects resembling the behavioral symptoms induced by 
some snake toxins such as cardiotoxins. These post- 
inoculation effects are apathy Followed by preliminary 
muscular tremors, convulsions, wasting, and spastic pa- 
ralysis just before death (15 min to 2 h). Moreover. the 
LDso of active Rev peptides were in the same range as 
those obtained with these snake toxins [18], or with a 
synthetic peptide mimicking the Tat basic region from 
49 to 57 [12]. This neurotoxic activity is specific, since 
a number of control peptides, including highly basic 
compounds, were inactive at the dose of 200 pug injected 
in mice. Further, a tryptic cleavage of the arginine-rich 
Rev peptides resulted in a complete loss of neurotox- 
icity. Although the full-length Rev proteins are not 
available to be tested in vivo, the results suggest the 
whole HIV and SlV Rev to be neurotoxic. 
Since interactions with specific phospholipids are 
thought to be responsible for pharmacological activities 
of some snake toxins, such as basic cardiotoxins [ 151. we 
have analyzed the tropism of active peptidcs for DLPS 
and DLPC using the monomolecular film technique. 
This approach permits to demonstrate a possible direct 
interaction of the Rev basic regions with only negatively 
charged DLPS, indicating the capacity of these scquen- 
ces to bind to specific components of the mcmbranc 
lipid bilaycr. Similar interaction with DLPS, but not 
DLPC, was previously obtained with curdiotoxins, or 
with the HIV-l Tat basic domain from 49 to 57 which 
was further reported to bc responsible for the binding 
of Tat to ccl1 mcmbrancs. Intcrcstingly, the pcptidc 
mimicking the HTLV-I Rex basic region from 1 to 17 
was unublc to pcnctratc thcsc phoapholipid films i:l 
spite of its highly basic characteristics (net clcctrical 
16 
charge of +9 at neutral pH) and the presence of partial 
sequence homology with the toxic basic region of Tat 
[19]. This result could be correlated with the lack of 
lethal activity found for the Rex peptide. May the dis- 
tinct activity of this peptide, as compared to other Rev 
basic domains, be related to a conformational particula- 
rism? 
In a recent report, CD was used to examine the con- 
formation of full-length HIV-l Rev [20]. The protein 
was estimated to contain approximately 50% a-helices, 
25% /?-sheets and 25% random coil when either bound 
or unbound to its target RRE sequence. It is worth 
noting that interaction of Rev with the RRE sequence 
is presumably mediated by the basic domain [2 11. Here, 
CD was used to compare the conformations of the Rev 
and Rex peptides solubilized in polar (water) and non- 
polar (TFE) solvents. The CD data show that toxic 
basic regions of Rev proteins exhibit comparable sec- 
ondary structures in each solvent, which are p-turns//J- 
sheets in water and cr-helices/,f?-sheets in TFE. Similar 
structures are obtained with the HIV-1 Tat basic do- 
main (data not shown). In contrast, the Rex peptide was 
structured exclusively in/3-turns in water and P-turns/@- 
sheets in TFE. The Rex peptide differs from Rev pep- 
tides by the presence of a cluster of proline residues at 
specific positions 2, 8, 16 and 27 close to or within its 
basic domain. The cluster of proline residues favors 
formation of B-turns which are indeed predominant in 
water (26%), while they prevent formation of cr-helices 
even in TFE which strongly stabilizes this conforma- 
tion. Considering that TFE mimicks the nonpolar envi- 
ronment of the membrane lipid bilayer, one can suppose 
the conformation of a given peptide in TFE to approach 
that adopted in the close neighborhood. Among the 
peptides tested, only the Rex peptide appears to be un- 
able to form a-helical structure in TFE. The lack of 
lethal activity of this peptide could thus be relied on its 
unability to form such a structure. Therefore. we specu- 
late that the lethal ncurotoxicity of active peptides 
depends on their structuration into or-helical conforma- 
tion during interaction with the membrane lipid bilayer. 
However, more investigations are required to study 
both the validity of this hypothesis and the physiologi- 
cal relevance of the potential Rev-rclatcd neurotoxicity. 
particularly in the neurological disorders associated 
with retroviral infection. 
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